使用冰冻切片细胞角蛋白-7免疫染色Mohs显微描记手术治疗乳腺外Paget病的多学科管理
回顾性研究纳入2009至2016年学术医疗中心多学科团队治疗的19例乳腺外Paget病患者共20个肿瘤,采用冰冻切片细胞角蛋白-7免疫染色Mohs显微描记手术(MMS-CK7)。平均随访75.2个月未见局部复发,多数患者对术后外观(18/19,95%)和功能(16/19,84%)满意,17例患者接受多专科内恶性肿瘤筛查并检出1例相关前列腺癌。
要点
- MMS-CK7联合多学科团队治疗EMPD,平均随访75.2个月未见局部复发。
- 术后患者对外观满意18/19(95%),对功能满意16/19(84%)。
- 17例患者接受多专科内恶性肿瘤筛查,检出1例相关前列腺癌。
核心结论
- 包含MMS-CK7的多学科团队可治疗EMPD,局部复发率低、患者满意度高,并完成彻底的内恶性肿瘤筛查。
研究设计与样本
- 回顾性研究,纳入2009年至2016年学术医疗中心多学科团队治疗的EMPD患者,共19例患者20个肿瘤,采用MMS-CK7治疗。
- 局部复发率与患者报告结局通过病历回顾和患者调查确定。
主要发现
- 19例患者共20个肿瘤接受MMS-CK7治疗;MMS-CK7确定显微镜下切缘阴性后,75%(15/20)的肿瘤由外科同事行切除或重建。
- 17例患者由多个专科完成内恶性肿瘤筛查,检出1例相关前列腺癌。
- 平均随访75.2个月,未检出局部复发。
- 术后对外观满意者18/19(95%),对功能满意者16/19(84%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To describe local recurrence rates and patient-reported outcomes when Mohs micrographic surgery with cytokeratin-7 immunostains (MMS-CK7) is included in the interdisciplinary management of extramammary Paget's disease (EMPD) METHODS: A retrospective study was conducted of EMPD treated with MMS-CK7 as part of an interdisciplinary team at an academic medical center between 2009 and 2016. Local recurrence rates and patient-reported outcomes were determined by record review and patient surveys. RESULTS: Twenty tumors in 19 patients were treated using MMS-CK7. After MMS-CK7 defined clear microscopic margins, 75% (15/20) of tumors underwent excision or reconstruction by a surgical colleague. Internal malignancy screening was performed by multiple specialties in 17 patients, with 1 associated malignancy of prostate cancer detected. No local recurrence was detected with a mean follow-up of 75.2 months. Most patients were satisfied with appearance (18/19, 95%) and function (16/19, 84%) after surgery. CONCLUSION: Interdisciplinary teams that include MMS-CK7 can treat EMPD with low local recurrence rates, high patient satisfaction, and thorough internal malignancy screening.
引用
- Bittar JM, Bittar PG, Nugent ST, et al. Interdisciplinary Management of Extramammary Paget's Disease Using Mohs Micrographic Surgery With Frozen Section Cytokeratin-7 Immunostains. Urology. 2022. PMID: 35561850. doi:10.1016/j.urology.2022.04.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。